Trials / Completed
CompletedNCT01424553
Respiratory Outcome at Adolescence of Very Low Birthweight Infants
Respiratory Outcome at Adolescence of Very Low Birthweight Infants : the EPIPAGE Cohort
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 355 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 14 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
EPIPAGEADO is an observational study. Respiratory symptoms and lung function will be evaluated in very low birth weight and term infants, born in 1997 and included in the French EPIPAGE cohort.
Detailed description
EPIPAGEADO is a multicenter observational study:- to evaluate respiratory symptoms and lung function at adolescence in very low birthweight (VLBW) children, to identify perinatal risk factors for persistent symptoms or impaired lung function tests at adolescence, to assess the exercise tolerance in VLBW children and to search for genetic susceptibility markers associated to impaired lung function. The main criteria for analysis will be the forced expiratory volume in one seconde (FEV1) The study duration will be 36 months the number of centers will be 4 centers in France (Paris-Necker, Nantes, Lille, Rouen) The number of patients to be included will be 400, including 260 VLBW children without BPD, 40 VLBW children with BPD, 100 control children with birth at term.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Prevention and follow-up of the patients pulmonary parameters | Respiratory symptoms and lung function will be evaluated in very low birth weight and term infants, born in 1997 and included in the French EPIPAGE cohort. |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2014-11-01
- Completion
- 2015-04-01
- First posted
- 2011-08-29
- Last updated
- 2025-09-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01424553. Inclusion in this directory is not an endorsement.